@article{17202, keywords = {Animals, Dapsone, Drug Resistance, Microbial, Drug Therapy, Combination, Humans, leprosy, Mice, Rifampin}, author = {Girdhar B K and Desikan K V}, title = {Persister M. leprae after introductory rifampicin followed by dapsone therapy.}, abstract = {

Lepromatous patients of "Introductory Rifampicin therapy' (Lepr. India, 50: 1978) who received 300 mg Rifampicin daily for 3 months followed by 50-100 mg DDS daily for another 21 months are investigated for persisters in the skin. Mouse foot pad results revealed that at the end of 2 years of treatment viable M. leprae are still persisting in 3 out of 6 patients.

}, year = {1981}, journal = {Leprosy in India}, volume = {53}, pages = {350-3}, month = {1981 Jul}, issn = {0024-1024}, language = {eng}, }